Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.57 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | GPR68 | Q15743 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29803065 | 1.00 | RAB9A (0.61) | RAB9AADORA2AADORA1ADORA2BPOLB | |
| SCHEMBL27795616 | 0.88 | RAB9A (0.49) | RAB9AADORA2AADORA1ADORA2BPOLB | |
| SCHEMBL27095783 | 0.85 | TAAR1 (0.56) | TAAR1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL4801904 | 0.85 | RAB9A (0.73) | RAB9AADORA2AADORA1ADORA2BPOLB | |
| SCHEMBL20904639 | 0.85 | RAB9A (0.50) | RAB9AADORA2AADORA1ADORA2BPOLB | |
| SCHEMBL6313572 | 0.84 | HSP90AA1 (0.67) | RAB9AADORA2AADORA1ADORA2BPOLB | |
| SCHEMBL13155157 | 0.82 | MAP4K4 (0.50) | RAB9AADORA2AADORA1ADORA2BTAAR1 | |
| SCHEMBL30933626 | 0.82 | MAP4K4 (0.50) | RAB9AADORA2AADORA1ADORA2BTAAR1 | |
| SCHEMBL27095780 | 0.79 | DPP4 (0.57) | ADORA2AADORA1ADORA2BTAAR1MEN1 | |
| SCHEMBL3421554 | 0.79 | RAB9A (0.66) | RAB9AADORA2AADORA1ADORA2BPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126325-A | Low-temperature-cured alkali-soluble photosensitive resin and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-06-04 | — | — | CN | claimed |
| WO-2024046225-A1 | ESTER TYPE PHOTOSENSITIVE POLYIMIDE COMPOSITE MATERIAL, PREPARATION METHOD AND SEMICONDUCTOR APPARATUS | 深圳先进电子材料国际创新研究院 | 2024-03-07 | — | — | WO | claimed |
| CN-115509088-A | Ester type photosensitive polyimide composite material, preparation method and semiconductor device | 深圳先进电子材料国际创新研究院 | 2022-12-23 | — | — | CN | claimed |
| CN-114805805-A | Polyimide with high bonding strength and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2022-07-29 | — | — | CN | claimed |
| CN-1820001-A | Substituted heterocyclic diarylamine analogues | NEUROGEN CORP (US) | 2006-08-16 | — | — | CN | claimed |
| CN-118126325-A | Low-temperature-cured alkali-soluble photosensitive resin and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024046225-A1 | ESTER TYPE PHOTOSENSITIVE POLYIMIDE COMPOSITE MATERIAL, PREPARATION METHOD AND SEMICONDUCTOR APPARATUS | 深圳先进电子材料国际创新研究院 | 2024-03-07 | — | — | WO | disclosed |
| US-11844802-B2 | Compounds and compositions for ossification and methods related thereto | EMORY UNIVERSITY (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230044670-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | UNIV EMORY (US) | 2023-02-09 | — | — | US | disclosed |
| CN-115509088-A | Ester type photosensitive polyimide composite material, preparation method and semiconductor device | 深圳先进电子材料国际创新研究院 | 2022-12-23 | — | — | CN | disclosed |
| US-11471461-B2 | Compounds and compositions for ossification and methods related thereto | EMORY UNIVERSITY (US) | 2022-10-18 | — | — | US | disclosed |
| US-11440906-B2 | Biguanide derivatives and their rearrangement products for use in the treatment of cancer | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-09-13 | — | — | US | disclosed |
| US-20170035771-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-02-09 | — | — | US | disclosed |
| US-9511071-B2 | Compounds and compositions for ossification and methods related thereto | EMORY UNIVERSITY (US) | 2016-12-06 | — | — | US | disclosed |
| EP-2605804-A2 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | Emory University (US) | 2013-06-26 | — | — | EP | disclosed |
| US-20130137634-A1 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2013-05-30 | — | — | US | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| WO-2012024489-A2 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2012-02-23 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| EP-0563386-A1 | ANTICANCER COMPOSITION AND COMPOUND | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1993-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137634-A1 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | BMP2, SOST, BMP4 | RAB9A 4649/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-11471461-B2 | Compounds and compositions for ossification and methods related thereto | BMP2, SOST, BMP4 | RAB9A 4649/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-20230044670-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | BMP2, SOST, BMP4 | RAB9A 4649/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-20170035771-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | BMP2, SOST, BMP4 | RAB9A 4649/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-11440906-B2 | Biguanide derivatives and their rearrangement products for use in the treatment of cancer | BCR, G6PD, BRAF | RAB9A 1659/4885ADORA2A 3916/4885ADORA1 4645/4885 |
| US-11844802-B2 | Compounds and compositions for ossification and methods related thereto | BMP2, SOST, BMP4 | RAB9A 4649/4885ADORA2A 181/4885ADORA1 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.